Anticoagulants (more commonly referred to as blood thinners) are routinely used to treat, prevent and reduce the risk of venous thromboembolism (VTE), which consists of prevent deep vein thrombosis (DVT) and pulmonary embolism (PE).
According to World Thrombosis Day, 1 in 4 people worldwide are dying from conditions caused by thrombosis:
How to Prevent Deadly Blood Clots: Three Free Resources from the Physician-Patient Alliance for Health & Safety
World Thrombosis Day asks us to be aware of tips to prevent deadly blood clots:
When you think of potentially deadly health issues, do you think of a blood clot? According to a recent U.S. survey, only 7 percent of people say they are concerned about blood clots, known by the medical term thrombosis. However, what they might not know is one in four people worldwide die from conditions caused by thrombosis, making it a leading cause of global death and disability.
In honor of WTD 2017, the Physician-Patient Alliance for Health & Safety believes that blood clots safety consists of four steps: Read More
Patient advocates and leading medical societies involved in awareness building and improving patient safety in Atrial Fibrillation (Afib) and venous thromboembolism (VTE) gathered recently for the 1st Annual Anticoagulation Summit, a two-day conference.
Michael Wong, JD, founder and Executive Director of the Physician-Patient Alliance for Health & Safety (PPAHS), presented a poster on the OB VTE Safety Recommendations, which were released by PPAHS, in collaboration with the Institute for Healthcare Improvement and the National Perinatal Association. The recommendations, compiled by a panel of health experts, give clinicians a step-by-step checklist to help assess all OB patients’ risks for VTE and identify the appropriate prophylaxis regimen to improve health outcomes for maternal patients. Read More
March is Blood Clot Awareness Month.
Spearheaded by the National Blood Clot Alliance, #BCAM is a time for patients, caregivers, healthcare professionals, and advocates to draw attention to deep vein thrombosis and venous thromboembolism.
According to the National Blood Clot Alliance:
“Blood clots do not discriminate. They can and do affect anyone from children to senior citizens, from professional athletes to mothers, women and men – no one is immune. Tragically, roughly 274 lives are lost each day in the U.S. simply because public awareness about life-threatening blood clots is so low.”
Blood Clot Awareness Month is a time for us to highlight stories and resources that you can share with colleagues, patients, and loved ones to bring attention to blood clots. Read More
The Physician-Patient Alliance for Health & Safety (PPAHS) released findings on practical solutions to prevent venous thromboembolism (VTE) in patients undergoing hip and knee replacement from its Orthopedic VTE Report.
The Physician-Patient Alliance for Health & Safety (PPAHS) released findings on practical solutions to prevent venous thromboembolism (VTE) in patients undergoing hip and knee replacement in its Orthopedic VTE Safety Report.
The survey gathered 41 respondents from across the United States and targeted experts in orthopedics. The majority of respondents indicated that they were either physicians (42.5%) or nurses (32.5%). Those who elected to identify themselves as “Other” largely fell within four self-identified professions: nurse practitioners, physical therapists, program managers, and pharmacists. About 3 in 5 respondents indicated that their primary work setting was in Orthopedics.
The following is an excerpt of an article on bundled payments for joint replacement written by Michael Wong, JD, Executive Director of PPAHS and Lynn Razzano, RN, MSN, ONCC, Clinical Nurse Consultant at PPAHS. It was first appeared on The Doctor Weighs In on November 18, 2016. To read the full article, please click here.
The Physician-Patient Alliance for Health & Safety has been invited to become a partner of World Thrombosis Day, an international multi-organizational campaign devoted to increasing global awareness about thrombosis, including its causes, risk factors, signs/symptoms, evidence-based prevention and treatments.
World Thrombosis Day aims to highlight the need for action on thrombosis, specifically underscoring the unrecognized threat and serious consequences (morbidity and mortality) related to venous thromboembolism (VTE).
The guidelines for preventing VTE after total joint arthroplasty (such as, knee and hip replacement) by the Academy of Orthopaedic Surgeons and American College of Chest Physicians are unanimous – both pharmacological and mechanical prophylaxis are needed.
The AAOS recommends the use of pharmacological and/or mechanical compression devices for both total hip arthroplasty (THA) and total knee replacement (TKA) patients who are not at an elevated risk for VTE or bleeding, as well as for patients with a known bleeding disorder and/or active liver disease.
To better understand and develop practical solutions to prevent venous thromboembolism (VTE) in patients undergoing hip and knee replacement, PPAHS asks for you to complete this survey on patient safety in orthopedics.
This survey has been sent to orthopedic surgeons and clinicians across the US. Read More